President Joe Biden’s job approval continues to crash with a new low of 36.4 percent during the first nine months of his presidency, according to a Zogby poll, after facing a botched Afghanistan withdrawal, and more recently, a supply chain crisis.
The Social Security Administration's plans to increase recipients' benefits by 5.9% next year could lead the Social Security Trust fund to run out of money by 2032, one year ahead of previous estimates, according to Maya MacGuineas, president of the bipartisan Committee for a Responsible Federal Budget.
Joe Biden’s U.S. Agency for International Development launched a new $125 million dollar project with Washington State University and foreign collaborators to discover over 10,000 novel viruses in nature.
A new paper in the European Journal of Epidemiology that analyzed 168 countries and 2,947 US counties found that higher vaccination rates were not associated with fewer COVID-19 cases.
Financial experts are pushing back against the Biden administration's proposal to include a provision in the $3.5 trillion spending bill to extend the IRS' reach to have bank transactions over $600 reported. The Democrats’ goal is to garner $463 billion in additional personal income tax over the next decade.
FDA notes lack of data regarding Moderna's booster vaccine "[u]se in pregnancy and while breastfeeding, long term safety, use in immunocompromised subjects, interaction with other vaccines, use in frail subjects and unstable health conditions and comorbidities, and use in subjects with autoimmune or inflammatory disorders."
Merck made headlines in early October when it announced the trial results of a newly developed antiviral pill that effectively reduced the risk of hospitalization and death by up to 50%.
